Table 1.

Clinical and laboratory findings, HLA class II alleles, β2GPI genotypes, and the number of β2GPI-reactive CD4+ T cell clones generated in patients with APS

PatientAge/sexClinical findingsAnti-β2GPI antibody*(U/mL)HLA class II allelesβ2GPI genotype at position 247Number of β2GPI-specific T-cell clones
ThrombosisPregnancy lossDRB1DRB4DRB5DQB1DPB1
O.M. 39/F Stroke > 125.0 *1501/*0403 *0103 *0101 *0602/*0302 *0201 247L/247
E.Y. 38/F DVT, PE N/A 92.9 *0901 *0103 — *0303 *0201 247V/247
K.S. 38/F Stroke > 125.0 *1502/*0901 *0103 *0102 *0601/*0303 *0501/*0901 247V/247
PatientAge/sexClinical findingsAnti-β2GPI antibody*(U/mL)HLA class II allelesβ2GPI genotype at position 247Number of β2GPI-specific T-cell clones
ThrombosisPregnancy lossDRB1DRB4DRB5DQB1DPB1
O.M. 39/F Stroke > 125.0 *1501/*0403 *0103 *0101 *0602/*0302 *0201 247L/247
E.Y. 38/F DVT, PE N/A 92.9 *0901 *0103 — *0303 *0201 247V/247
K.S. 38/F Stroke > 125.0 *1502/*0901 *0103 *0102 *0601/*0303 *0501/*0901 247V/247

DVT indicates deep venous thrombosis of lower extremity; PE, pulmonary embolism; N/A, not applicable.

*

Normal range < 3.5 U/mL.

A valine (247V) to leucine (247L) amino acid dimorphism was determined by RsaI digestion of the PCR-amplified DNA.

Close Modal

or Create an Account

Close Modal
Close Modal